<unk>  is an endocrine-metabolic agent that is FDA approved for the treatment of type 2 diabetes mellitus.   Common adverse reactions include female genital mycotic infections, nasopharyngitis, and urinary tract infections.
Dapagliflozin
Canagliflozin
Linagliptin
Empagliflozin
Liraglutide
Vildagliptin
Pioglitazone
Exenatide